| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 07/31/2013 | CN101443017B Medication against breast cancer and related diseases |
| 07/31/2013 | CN101412742B Nitric acid ester medicament for inhibiting angiogenesis |
| 07/31/2013 | CN101404995B Lignane compound-containing oil-in-water emulsion and composition comprising the same |
| 07/31/2013 | CN101402562B Novel benzophenone derivatives or salts thereof |
| 07/31/2013 | CN101312734B A therapeutic composition containing an organosilane quaternary compound and hydrogen peroxide for treating skin disorders |
| 07/31/2013 | CN101072758B 喹唑啉衍生物 Quinazoline derivatives |
| 07/31/2013 | CA2766474A1 Post-exposure therapy of influenza a infections |
| 07/30/2013 | USRE44400 Compositions comprising Lactobacillus plantarum strains in combination with tannin and new Lactobacillus plantarum strains |
| 07/30/2013 | US8497397 Substituted acrylamide derivative and pharmaceutical composition comprising the same |
| 07/30/2013 | US8497383 HIV protease inhibitors |
| 07/30/2013 | US8497382 Carboxylic acid derivative containing thiazole ring and pharmaceutical use thereof |
| 07/30/2013 | US8497381 Antagonists of prostaglandin D2 receptors |
| 07/30/2013 | US8497380 Substituted acetophenones useful as PDE4 inhibitors |
| 07/30/2013 | US8497379 Method and intermediates for the preparation of 2,2,2-trifluoro-N-(4-fluoro-3-pyridin-4-yl-benzyl)-acetamide hydrochloride |
| 07/30/2013 | US8497373 Phosphonic acid compounds as inhibitors of serine proteases |
| 07/30/2013 | US8497370 Processes for preparing amine salts of sildenafil-analogues and use thereof |
| 07/30/2013 | US8497368 Heterocyclic hydrazone compounds |
| 07/30/2013 | US8497351 Nucleic acid and corresponding protein entitled 162P1E6 useful in treatment and detection of cancer |
| 07/30/2013 | US8497307 Aryl guanidine F1F0-ATPase inhibitors and related methods |
| 07/30/2013 | US8497305 Phenylcyclobutylamide derivatives and their stereoisomers, the preparation processes and uses thereof |
| 07/30/2013 | US8497304 Aqueous liquid preparation containing 2-amino-3-(4-bromobenzoyl)phenylacetic acid |
| 07/30/2013 | US8497303 Method to enhance aqueous solubility of poorly soluble actives |
| 07/30/2013 | US8497302 Microbiological method for synthesizing cinnamoyl amide derivatives of amino acids |
| 07/30/2013 | US8497301 Hydroxyl compounds and compositions for cholesterol management and related uses |
| 07/30/2013 | US8497299 Compositions including quinonoid derivatives of cannabinoids for therapeutic use |
| 07/30/2013 | US8497298 Use of benzo-fused heterocycle sulfamide derivatives for lowering lipids and lowering blood glucose levels |
| 07/30/2013 | US8497297 Dimeric IAP inhibitors |
| 07/30/2013 | US8497296 N,N′-hydrazino-bis-isatin derivatives with selective activity against multidrug-resistant cancer cells |
| 07/30/2013 | US8497295 Spiroindoline modulators of muscarinic receptors |
| 07/30/2013 | US8497294 Compositions comprising (S)-2-amino-1-(4-chlorophenyl)-1-[4-(1H-pyrazol-4-yl)-phenyl]-ethanol as modulator of protein kinases |
| 07/30/2013 | US8497292 Translational dysfunction based therapeutics |
| 07/30/2013 | US8497291 Crystalline pyrimidine nucleoside derivative suspensions in capsules |
| 07/30/2013 | US8497290 Thiocolchicine derivatives, method of making and methods of use thereof |
| 07/30/2013 | US8497289 3.1.0 bicyclic GlyT1 inhibitors and methods of making and using same |
| 07/30/2013 | US8497288 Hexahydropyrroloimidazolone compounds |
| 07/30/2013 | US8497286 Organic compounds |
| 07/30/2013 | US8497285 Therapy of autoimmune colitis using a TIP60 inhibitor |
| 07/30/2013 | US8497284 C-met modulators and method of use |
| 07/30/2013 | US8497283 Autotaxin inhibitors |
| 07/30/2013 | US8497282 Method of preparing (+)-1,4-dihydro-7-[(3S,4S)-3-methoxy-4-(methylamino)-1-pyrrolidinyl]-4-oxo-1-(2-thiazolyl)-1,8-naphthyridine-3-carboxylic acid |
| 07/30/2013 | US8497281 Aryl- and heteroarylcarbonyl derivatives of hexahydroindenopyridine and octahydrobenzoquinoline |
| 07/30/2013 | US8497280 Medicinal compositions comprising buprenorphine and nalmefene |
| 07/30/2013 | US8497279 Treatment for discoid lupus |
| 07/30/2013 | US8497278 Imidazo[1,2-a]pyridine compounds |
| 07/30/2013 | US8497277 Inhibitors of Bruton's tyrosine kinase |
| 07/30/2013 | US8497276 Substituted indolo-piperidine compounds |
| 07/30/2013 | US8497275 HCV protease inhibitors and uses thereof |
| 07/30/2013 | US8497273 Heterocyclic compounds suitable for treating disorders that respond to modulation of the serotonin 5HT6 receptor |
| 07/30/2013 | US8497272 Compounds for treating proliferative disorders |
| 07/30/2013 | US8497271 Modulators of G protein-coupled receptor 88 |
| 07/30/2013 | US8497270 Macrocyclic integrase inhibitors |
| 07/30/2013 | US8497269 Phthalazine compounds as p38 map kinase modulators and methods of use thereof |
| 07/30/2013 | US8497268 Method for providing blood levels of eszopiclone with maleate salts |
| 07/30/2013 | US8497267 Method for treating a sleep disorder with a dosage form of besylate salts of zopiclone or eszopiclone |
| 07/30/2013 | US8497266 3-(3-pyrimidin-2-ylbenzyl)-1,2,4-triazolo[4,3-b]pyridazine derivatives as MET kinase inhibitors |
| 07/30/2013 | US8497265 Heteroaryloxyheterocyclyl compounds as PDE10 inhibitors |
| 07/30/2013 | US8497264 Amino-oxazines and amino-dihydrothiazine compounds as beta-secretase modulators and methods of use |
| 07/30/2013 | US8497263 Pyrrolinone derivative and pharmaceutical composition comprising the same |
| 07/30/2013 | US8497262 Therapeutic pyrazolonaphthyridine derivatives |
| 07/30/2013 | US8497261 3-aminocaprolactam compounds for treating inflammatory disorders |
| 07/30/2013 | US8497260 2-arylbenzothiophene derivatives or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition for the diagnosis or treatment of degenerative brain disease containing the same as active ingredient |
| 07/30/2013 | US8497259 Cholesterol control agent |
| 07/30/2013 | US8497258 Viscous budesonide for the treatment of inflammatory diseases of the gastrointestinal tract |
| 07/30/2013 | US8497257 Methods of use for 2,5-dihydroxybenzene sulfonic acid compounds for the treatment of cancer, rosacea and psoriasis |
| 07/30/2013 | US8497256 Formulations and uses of 2-hydroxy-5-phenylazobenzoic acid derivatives for the treatment of males |
| 07/30/2013 | US8497255 Phosphonic acids as S1P receptor modulators |
| 07/30/2013 | US8497254 Oxadiazole derivatives as sphingosine 1-phosphate (S1P) receptor modulators |
| 07/30/2013 | US8497253 Administration form of osteogenic protein complexes |
| 07/30/2013 | US8497249 Fungicidal properties of three saponins from Capsicum frutescens |
| 07/30/2013 | US8497248 Antifungal paints and coatings |
| 07/30/2013 | US8497070 Angiogenin mutations and amyotrophic lateral sclerosis or motor neuron disease |
| 07/30/2013 | US8496979 Caffeine-free dietary supplements for increasing energy and methods of administering the same |
| 07/30/2013 | US8496975 Compositions for the treatment and prevention of infections of the oral cavity |
| 07/30/2013 | US8496965 Pellet formulation for the treatment of the intenstinal tract |
| 07/30/2013 | US8496964 Controlled release micro-capsule for osteogenic action |
| 07/30/2013 | US8496961 Delivery of nucleic acid-like compounds |
| 07/30/2013 | US8496960 Contains amorphous terazosin; treating benign prostatic hypertrophy; maximizes the dosage interval and minimizes the plasma concentrations and or fluctuations in plasma concentrations |
| 07/30/2013 | US8496958 Compositions and methods for the sustained release of beta-alanine |
| 07/30/2013 | US8496957 Controlled release auris sensory cell modulator compositions and methods for the treatment of otic disorders |
| 07/30/2013 | US8496951 Compositions containing aromatic aldehydes and their use in treatments |
| 07/30/2013 | US8496917 Compositions and methods for improving skin appearance |
| 07/30/2013 | CA2790087C Viral inhibitor compositions for in vivo therapeutic use comprising a combination of (-)-carvone, (+)-carvone, geraniol and a further essential oil component |
| 07/30/2013 | CA2720800C Capsule for the prevention of cardiovascular diseases |
| 07/30/2013 | CA2714700C Heterocyclic compounds and compositions as c-kit and pdgfr kinase inhibitors |
| 07/30/2013 | CA2701023C Methods and formulations for converting intravenous and injectable drugs into oral dosage forms |
| 07/30/2013 | CA2678092C Bilayer composition for the sustained release of acetaminophen and tramadol |
| 07/30/2013 | CA2678008C Methods of treating a secondary bone tumor with anti-pdgfralpha antibodies |
| 07/30/2013 | CA2676444C Prodrugs of substituted 1,3-dioxanes and their uses |
| 07/30/2013 | CA2659549C Compositions and methods relating to novel compounds and targets thereof |
| 07/30/2013 | CA2651634C Substituted piperidino phenyloxazolidinones |
| 07/30/2013 | CA2645058C Pharmaceutical composition for external use |
| 07/30/2013 | CA2641453C Thiadiazole derivatives for the treatment of neuro degenerative diseases |
| 07/30/2013 | CA2634006C Pharmaceutical sustained release compositions comprising liothyronine or the sodium salt of liothyronine |
| 07/30/2013 | CA2610711C Use of polydextrose for simulating the functional attributes of human milk oligosaccharides in formula-fed infants |
| 07/30/2013 | CA2610638C Use of agomelatine to obtain drugs intended for the treatment of smith-magenis syndrome |
| 07/30/2013 | CA2604768C Mucoadhesive xyloglucan-containing formulations useful in medical devices and in pharmaceutical formulations |
| 07/30/2013 | CA2599611C Meleimide derivatives, pharmaceutical compositions and methods for treatment of cancer |
| 07/30/2013 | CA2599538C N-sulphonylpyrroles and their use as histone deacetylase inhibitors |
| 07/30/2013 | CA2599252C Carnitine-containing peritoneal dialysis solution having improved biocompatibility |
| 07/30/2013 | CA2598331C Amide derivatives of hyaluronic acid in osteoarthrosis |